QSP 7.3-3 R9 Risk Management

TULIP MEDICAL CORPORATION
Quality System Procedure
Document Control Number: QSP 7.3-3
Revision: R9
Effective Date: 2024-01-15
Prepared by: Quality Manager
Approved by: Regulatory Affairs Coordinator

1. PURPOSE
This procedure establishes the requirements for risk management activities throughout the product lifecycle to ensure patient safety and regulatory compliance with ISO 14971 and FDA guidance.

2. SCOPE
This procedure applies to all medical devices developed, manufactured, and distributed by Tulip Medical Corporation, including software as medical devices (SaMD) and combination products.

3. RESPONSIBILITIES

3.1 Risk Management Team
The risk management team shall be responsible for conducting comprehensive risk analysis, implementing risk control measures, and maintaining risk management files for all medical devices.

3.2 Design and Development Team
The design team shall integrate risk management activities into the design and development process, ensuring that risk controls are implemented at the design level.

4. PROCEDURE

4.1 Risk Management Planning
Risk management planning shall be initiated during the early stages of product development and shall include identification of intended use, reasonably foreseeable misuse, and applicable standards.

4.2 Risk Analysis
Risk analysis shall be conducted using systematic methods to identify hazards, estimate risks, and evaluate risk acceptability according to established criteria.

4.2.1 Hazard Identification
All potential hazards associated with the medical device shall be identified through systematic analysis including failure mode analysis, use error analysis, and clinical risk assessment.

4.2.2 Risk Estimation
For each identified hazard, the probability of occurrence and severity of harm shall be estimated using quantitative or qualitative methods as appropriate for the device complexity.

4.3 Risk Evaluation
Risk evaluation shall determine whether identified risks are acceptable based on established risk acceptability criteria and regulatory requirements.

5. RECORDS
Risk management activities shall be documented in the risk management file, including risk analysis reports, risk control implementation records, and post-market surveillance data.

SIGNATURE BLOCK
Document Control Coordinator: _________________ Date: _________
Quality Manager: _________________ Date: _________
Regulatory Affairs Manager: _________________ Date: _________

Form 7.3-3-1: Risk Management Plan Template
Form 7.3-3-2: Risk Analysis Worksheet
Page 1 of 15
Rev 9
